Advertisement
Your vote in support of the merger on the WHITE proxy card is veryimportant
With the Annual Meeting just a week away on September 20, we urge you tovote your WHITE proxy card NOW in support of our $45.50 per share merger withTeleflex. By voting the WHITE proxy card, and voting to approve thistransaction and re-elect all of the members of your current Board ofDirectors, you can help assure that the merger is completed and that you willreceive your cash payment.
Advertisement
Your vote to re-elect Arrow's director-nominees is also very important
If you are in favor of the Teleflex merger, we believe it is in your bestinterests to vote to re-elect your current Board of Directors. Thesedirectors are experienced, dedicated and fully committed to completing theTeleflex merger and protecting the interests of all Arrow shareholders. Yourcurrent Board of Directors initiated the strategic alternatives process thatresulted in the $45.50 per share cash offer from Teleflex.
Do NOT add risk by voting for the McNeil Trust
There is no need to add uncertainty to the merger closing process byelecting new directors, as the McNeil Trust is attempting to do. The McNeilTrust opposed the strategic alternatives process from the beginning and voicedsupport for the merger only after the transaction was publicly announced.There is a difference between being committed to a transaction and merelyagreeing to vote for it. We do not think it is in your best interest to allownominees of a shareholder who is not committed to completing this mergerhandle any issues that may arise between the approval of the merger agreementand the closing of the transaction. We believe the McNeil Trust's nomineesare not the best option for shareholders. We believe their slate presentsadded risk to the transaction, and in the unlikely event the merger is notconsummated, the Trust's slate offers only a return to the disappointmentsthat existed when the current Board of Directors decided to explore strategicalternatives. We strongly urge you NOT to sign or return any blue proxy cardsto the McNeil Trust.
Please vote the WHITE proxy card today
If your shares are held by your brokerage firm or bank, you must providethem with instructions on how to vote on your behalf or they will be unable tovote your shares on certain issues, including the adoption of the mergeragreement. Given that time is short, we encourage you to follow theinstructions on the enclosed form to vote by telephone or Internet.
If you have any questions or would like assistance in voting your sharesof Arrow common stock, please call our proxy solicitor, Morrow & Co., Inc.,toll-free at 1-800-662-5200.
About Arrow
Arrow develops, manufactures and markets a broad range of clinicallyadvanced, disposable catheters and related products for critical and cardiaccare. The company's products are used primarily by anesthesiologists, criticalcare specialists, surgeons, emergency and trauma physicians, cardiologists,interventional radiologists and other healthcare providers. Arrow's newsreleases and other company information can be found on the World Wide Web athttp://www.arrowintl.com . Arrow's common stock trades on the NASDAQ GlobalSelect Market(TM) under the symbol ARRO.
Additional Information
In connection with the proposed acquisition of Arrow by TeleflexIncorporated and Arrow's 2007 Annual Meeti
